Medtronic Plc
(NYSE : MDT)

( )
MDT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
3.14%85.770.8%$416.49m
MDTMedtronic PLC
1.07%100.940.6%$402.92m
TMOThermo Fisher Scientific Inc.
0.26%286.961.0%$368.20m
ISRGIntuitive Surgical, Inc.
1.54%523.502.4%$342.56m
BDXBecton, Dickinson and Company
0.18%251.831.1%$290.46m
ALGNAlign Technology, Inc.
1.01%283.916.3%$283.19m
EWEdwards Lifesciences Corporation
1.16%189.711.2%$260.81m
BSXBoston Scientific Corporation
0.91%42.241.1%$230.16m
SYKStryker Corporation
1.24%207.951.3%$213.55m
BAXBaxter International Inc.
0.77%82.701.7%$176.59m
ZBHZimmer Biomet Holdings, Inc.
0.78%123.041.7%$148.92m
DXCMDexCom, Inc.
-1.52%147.578.3%$145.58m
WATWaters Corporation
-0.90%212.883.8%$126.06m
ABMDABIOMED, Inc.
2.49%260.063.3%$112.76m
COOCooper Companies, Inc.
0.97%331.372.2%$93.54m

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.